Blockchain Registration Transaction Record

Oncotelic’s PDAOAI Platform to Debut at Qdrant Vector Space Day

Oncotelic Therapeutics showcases PDAOAI platform at Qdrant Vector Space Day, accelerating drug discovery with AI and vector search. Learn how OTLC reduces development time and cost.

This news matters because it highlights a breakthrough in AI-driven drug discovery that could significantly reduce the time and cost of bringing new oncology treatments to market. For patients, this means faster access to potentially life-saving therapies. For investors, Oncotelic’s demonstrated efficiency in advancing drug candidates underscores the platform’s value and the company’s potential to disrupt traditional pharmaceutical development.